Drug Type Autologous CAR-T |
Synonyms TBI-2001 |
Target |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
CD19 positive B-Cell Lymphoma | Phase 1 | CA | 26 Jul 2023 | |
Chronic Lymphocytic Leukemia | Phase 1 | CA | 26 Jul 2023 | |
Small Lymphocytic Lymphoma | Phase 1 | CA | 26 Jul 2023 | |
Hematologic Neoplasms | Phase 1 | JP | 07 Sep 2021 |